Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients

Pediatric Nephrology

Volumn 20, Issue 1, 2005, Pages 64-68

  Robinson, Renee F ^a   Nahata, Milap C ^a   Sparks, Elizabeth ^a   Daniels, Curt ^a   Batisky, Donald L ^a   Hayes, John R ^a   Mahan, John D ^a  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiovascular function; Hemodialysis; Peritoneal dialysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ARTERIOSCLEROSIS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHILD; CHILD UROLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIALYSIS; DISEASE COURSE; DISEASE MARKER; FEMALE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; UREMIA;

ADOLESCENT; AORTA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; DIALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INFANT; KIDNEY FAILURE, CHRONIC; MALE; ORGAN SIZE; PERITONEAL DIALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 11244323936     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1667-x     Document Type: Article

References (47)

1. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 61:621-629
2. Greaves SC, Sharpe DN (1992) Cardiovascular disease in patients with end-stage renal failure. Aust N Z J Med 22:153-159
3. (1992) Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38
4. Wizemann V, Schafer R, Kramer W (1993) Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy. Nephron 64:202-206
5. London GM, De Vernejoul MC, Fabiani F, Marchais SJ, Guerin AP, Metivier F, London AM, Llach F (1987) Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900-907
6. de Lima JJ, Abensur H, Krieger EM, Pileggi F (1996) Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients. J Hypertens 14:1019-1024
7. Conion PJ, Walshe JJ, Heinle SK, Minda S, Krucoff M, Schwab SJ (1996) Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol 7:2658-2663
8. White WB (1992) Impact of the daily blood pressure load on the development of hypertensive heart disease. Cardiology 81:299-306
9. Groothoff JW, Gruppen MP, Offringa M, De Groot E, Stok W, Bos WJ, Davin JC, Lilien MR, Van De Kar NC, Wolff ED, Heymans HS (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953-2961
10. Cannella G, Paoletti E, Ravera G, Cassottana P, Araghi P, Mulas D, Peloso G, Delfino R, Messa P (2000) Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 58:260-268
11. London GM (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17 [Suppl 1]:29-36
12. London G (2001) Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 16 [Suppl] 2:3-6
13. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759-2767
14. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre PE (1988) Congestive heart failure in dialysis patients. Arch Intern Med 148:1519-1525
15. Belsha CW, Wells TG, McNiece KL, Seib PM, Plummer JK, Berry PL (1998) Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 11:410-417
16. Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907-1911
17. Daniels SR (1999) Hypertension-induced cardiac damage in children and adolescents. Blood Press Monit 4:165-170
18. Daniels SR (2002) Cardiovascular sequelae of childhood hypertension. Am J Hypertens 15:61S-63S
19. Chamontin B, Amar J, Barthe P, Salvador M (1994) Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up. J Hum Hypertens 8:357-361
20. Sorof JM, Cardwell G, Franco K, Portman RJ (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903-908
21. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ (2003) Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111:61-66
22. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566
23. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385
24. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439
25. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574
26. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103:987-992
27. Pasierski TJ, Binkley PF, Pearson AC (1992) Evaluation of aortic distensibility with transesophageal echocardiography. Am Heart J 123:1288-1292
28. Wright JS, Cruickshank JK, Kontis S, Dore C, Gosling RG (1990) Aortic compliance measured by non-invasive Doppler ultrasound: Description of a method and its reproducibility. Clin Sci 78:463-468
29. Matsumoto Y, Hamada M, Hiwada K (2000) Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 51:933-941
30. Troy BL, Pombo J, Rackley CE (1972) Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 45:602-611
31. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 58:1072-1083
32. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458
33. (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98:649-658
34. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470-479
35. Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290
36. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024-2031
37. Matsumoto Y, Honda T, Hamada M, Matsuoka H, Hiwada K (1996) Evaluation of aortic distensibility in patients with coronary artery disease by use of cine magnetic resonance. Angiology 47:149-155
38. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236-1241
39. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS (1992) The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117:831-836
40. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736
41. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C (2001) Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 16:1459-1464
42. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E (1993) Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:1451-1457
43. Van Bortel LM, Struijker-Boudier HA, Safar ME (2001) Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 38:914-921
44. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22-30
45. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350: 1349-1353
46. Strozecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Wlodarczyk Z, Manitius J (2001) Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 23:115-126
47. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS (2000) Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 20:396-401